These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 19144670

  • 1. Fibrates: where are we now?
    Seth Loomba R, Arora R.
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):91-6. PubMed ID: 19144670
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
    Tenenbaum A, Fisman EZ.
    Cardiovasc Diabetol; 2012 Oct 11; 11():125. PubMed ID: 23057687
    [Abstract] [Full Text] [Related]

  • 5. Fibrates in combination with statins in the management of dyslipidemia.
    Jacobson TA, Zimmerman FH.
    J Clin Hypertens (Greenwich); 2006 Jan 11; 8(1):35-41; quiz 42-3. PubMed ID: 16407687
    [Abstract] [Full Text] [Related]

  • 6. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
    Soska V.
    Vnitr Lek; 2011 Mar 11; 57(3):313-6. PubMed ID: 21495414
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Multimodal therapy of dyslipidemia].
    Stahn A, Hanefeld M.
    Clin Res Cardiol Suppl; 2011 May 11; 6():10-6. PubMed ID: 22528173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic interactions between statins and fibrates.
    Corsini A, Bellosta S, Davidson MH.
    Am J Cardiol; 2005 Nov 07; 96(9A):44K-49K; discussion 34K-35K. PubMed ID: 16291014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibrates but not statins increase plasma selenium in dyslipidemic aged patients--the EVA study.
    Arnaud J, Akbaraly TN, Hininger-Favier I, Berr C, Roussel AM.
    J Trace Elem Med Biol; 2009 Nov 07; 23(1):21-8. PubMed ID: 19203713
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy of statins and fibrates in the management of cardiovascular risk.
    Fiévet C, Staels B.
    Curr Opin Lipidol; 2009 Dec 07; 20(6):505-11. PubMed ID: 19829109
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.